Literature DB >> 2857154

Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.

M Oda, J L Cowell, D G Burstyn, S Thaib, C R Manclark.   

Abstract

Colostrum samples from Indonesian mothers were assayed for antibodies which agglutinate Bordetella pertussis and for antibodies to the filamentous hemagglutinin and the lymphocytosis-promoting factor of B. pertussis. Agglutinins were assayed by a microtiter method, and 36 of 58 samples tested (62%) had titers above 1:10 (range, less than 1:10 to 1:160). An enzyme-linked immunosorbent assay detected anti-filamentous hemagglutinin in 39 of 60 samples (65%) and anti-lymphocytosis-promoting factor in 26 of 60 samples assayed (43%). A total of 52 samples (87%) were positive for at least one of these antibodies. Pooled colostrum samples were separated by affinity chromatography into fractions enriched secretory immunoglobulin A (sIgA) or IgG and examined for their ability to passively protect suckling mice from aerosol challenge with B. pertussis. Samples (160 micrograms of protein) were given intraperitoneally 90 min before challenge. Death, rate of gain in body weight, and leukocytosis were used as indicators of illness. Colostrum containing anti-lymphocytosis-promoting factor or agglutinins was protective, whereas colostrum lacking these but containing anti-filamentous hemagglutinin gave little protection. The sIgA-enriched and IgG-enriched fractions appeared to be equal in their ability to protect against respiratory challenge with B. pertussis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857154      PMCID: PMC263189          DOI: 10.1128/iai.47.2.441-445.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

Authors:  M Pittman
Journal:  Rev Infect Dis       Date:  1979 May-Jun

2.  Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.

Authors:  L A Ashworth; L I Irons; A B Dowsett
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

3.  Separation and purification of the hemagglutinins from Bordetella pertussis.

Authors:  Y Sato; J L Cowell; H Sato; D G Burstyn; C R Manclark
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

Review 4.  Bordetella pertussis toxins.

Authors:  A C Wardlaw; R Parton
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

5.  Chlamydial secretory IgA antibodies in human milk.

Authors:  K Skaug; A B Otnaess; I Orstavik; F Jerve
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-02

6.  Protective properties of anticholera antibodies in human colostrum.

Authors:  A S Majumdar; A C Ghose
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Metabolism of immunoglobulin A in lactating mice: origins of immunoglobulin A in milk.

Authors:  J F Halsey; C Mitchell; R Meyer; J J Cebra
Journal:  Eur J Immunol       Date:  1982-02       Impact factor: 5.532

8.  Antibacterial and antitoxin responses in the serum and milk of cholera patients.

Authors:  A S Majumdar; P Dutta; D Dutta; A C Ghose
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

9.  Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine.

Authors:  M Oda; K Izumiya; Y Sato; M Hirayama
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

10.  Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.

Authors:  D G Burstyn; L J Baraff; M S Peppler; R D Leake; J St Geme; C R Manclark
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  3 in total

1.  Infection of newborn piglets with Bordetella pertussis: a new model for pertussis.

Authors:  S Elahi; R Brownlie; J Korzeniowski; R Buchanan; B O'Connor; M S Peppler; S A Halperin; S F Lee; L A Babiuk; V Gerdts
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.

Authors:  A Kimura; K T Mountzouros; D A Relman; S Falkow; J L Cowell
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

3.  A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

Authors:  K H Mills; M Ryan; E Ryan; B P Mahon
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.